Internal Medicine, Endocrinology, Diabetes, & Metabolism · Sewickley, PA
NPI
1720033244
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
701 Broad St Ste 421
Sewickley, PA, 15143
Phone (412) 741-2552
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
1,091 services
Medicare patients, 2024
431
Average age 72
Drug cost, 2024
$3.7M
9,670 prescriptions
Company payments, 2025
$2,115
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerald M Goltz was code 99214 (office e&m - established), 616 times for 357 patients. In total Gerald M Goltz billed 1,091 services in 14 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 616 | 357 | $76.45 | $47K |
| 99215 Office E&M - Established | Office | 181 | 131 | $125.54 | $23K |
| 95251 Test - Miscellaneous | Office | 89 | 44 | $25.58 | $2,277 |
| 99232 Hospital E&M - Subsequent | Facility | 85 | 18 | $59.53 | $5,060 |
| 99213 Office E&M - Established | Office | 45 | 32 | $51.47 | $2,316 |
| 99222 Hospital E&M - Initial | Facility | 20 | 18 | $93.80 | $1,876 |
By year: 2022 $86K for 1,149 services; 2023 $81K for 1,124 services; 2024 $86K for 1,091 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gerald M Goltz prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,300 prescriptions and refills. In total Gerald M Goltz wrote 9,670 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,300 | 3,448 | 341 | $16K |
| Metformin Hcl Generic | 754 | 2,023 | 226 | $5,538 |
| Synthroid Levothyroxine Sodium | 517 | 1,354 | 125 | $40K |
| Ozempic Semaglutide | 510 | 807 | 121 | $769K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 389 | 973 | 140 | $49K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 359 | 910 | 115 | $56K |
| Atorvastatin Calcium Generic | 355 | 936 | 100 | $3,821 |
| Jardiance Empagliflozin | 242 | 511 | 60 | $290K |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 203 | 299 | 40 | $265K |
| Simvastatin Generic | 193 | 497 | 52 | $1,568 |
| Mounjaro Tirzepatide | 177 | 250 | 35 | $259K |
| Rosuvastatin Calcium Generic | 148 | 347 | 46 | $2,448 |
| Ezetimibe Generic | 148 | 421 | 48 | $4,471 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 139 | 243 | 25 | $153K |
| Tradjenta Linagliptin | 139 | 230 | 23 | $113K |
Brand drugs: 4,228 claims; generic drugs: 4,489 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gerald M Goltz $2,115 ($2,115 in general payments such as food, travel and fees) from 25 companies. The largest payer was Novo Nordisk Inc with $304.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 16 | $304 |
| Lilly USA, LLC LLY | 14 | $291 |
| Ascendis Pharma Endocrinology Inc ASND | 10 | $175 |
| Amgen Inc. AMGN | 8 | $141 |
| Dexcom, Inc. DXCM | 12 | $135 |
| Amphastar Pharmaceuticals, Inc. AMPH | 6 | $116 |
| Tandem Diabetes Care, Inc. TNDM | 8 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $100 |
| Xeris Pharmaceuticals, Inc. | 4 | $81.08 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $70.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.